The True Cost of Stopping and Restarting a GLP-1

Whether to pause a GLP-1 is a conversation with a prescriber and nothing on this page speaks to it. What this page can tell you is that the pricing structures in this market are built so that stopping is free and restarting is not — and that almost none of that cost is visible when you sign up.

Five mechanisms. Each of them is published, and each has a number.

One: you are no longer a new patient

Novo's introductory price is the one most people expect to fall back on. Its footnote closes that door: "Patients new to Wegovy® Savings Offer & NovoCare® Pharmacy pay $199 for each month of 0.25 mg and 0.5 mg. Offer for 2 monthly fills through December 31, 2026, then $349 per month."¹

New to the offer, and new to the pharmacy. If you used both on your first course, a restart begins at $349. The Ozempic® pen offer is worded the same way.²

What it costs: $150 more on each of your first two fills back. $300.

Two: the 45-day clock does not forgive a gap

Lilly's self-pay prices for Zepbound® — $299, $399 and $449 — hold only on a refill within 45 days of the last delivery. Outside that window the same prescription bills at Lilly's regular prices, which the page gives as $499 to $699.³

A pause is, by definition, outside the window. Ro, which resells the same branded product, prints the ladder in detail: $499 at 7.5 mg and $699 at 10 mg and above when the refill check-in is late, against $449 either way when it is on time.⁴

What it costs: up to $250 on the first fill back, at the top of the ladder.

Three: what you prepaid does not come back with you

Prepaid plans are the cheapest monthly rate in this market and the most expensive way to stop.

Found's advertised $169 a month is footnoted "Pricing based on 12-month plans paid up-front", against $289 a month on the monthly plan.⁵ Twelve months at $169 is $2,028 handed over on day one. Stop in month four and eight months of plan are already paid.

Ro's cheapest membership tier is "$74/mo 12-month plan prepaid annually" — $888 committed at signup — against $149 a month on the monthly plan. The only refund Ro's pricing page promises is the $39 start fee, returned "if you're not eligible for GLP-1s".⁶

What it costs: whatever fraction of the term you do not use. On Ro's annual plan, stopping at month four leaves $592 of prepaid membership unused.

Four: the savings card runs on a calendar, not on your course

Manufacturer cards cap what they will pay per year, and the year is the calendar's, not yours.

Lilly's Mounjaro® card caps savings at $150 a month and $1,950 per calendar year for commercially insured patients with coverage, or $647 a month and $8,411 per calendar year without it. Both state that the card expires and savings end on 31 December 2026.⁷

Novo's commercial-insurance offers are capped at a maximum saving of $100 a month, with government beneficiaries excluded.¹

Stop in June and restart in November and you have spent five months of a calendar-year allowance on nothing. The allowance does not follow you.

Five: the one thing that goes your way

On a laddered product, restarting lower down the ladder is genuinely cheaper — LillyDirect's 2.5 mg tier is $299 against $449 at the top, and Novo's tablet is $149 at 1.5 mg against $299 at maintenance.¹ Whether a prescriber restarts anyone anywhere in particular is a clinical decision and not a pricing one, but if it happens, the bill reflects it.

On a flat-priced product — Mounjaro at $499 for every strength, or a compounded plan charging one price at any dose — there is no such relief. You come back at exactly the price you left.

A worked restart

A reader paying $449 a month for Zepbound at the 10 mg tier pauses for three months and comes back.

First fill back, outside the 45-day window, at Lilly's regular price for that tier as detailed on Ro's page: $699. That is $250 more than the on-time price.

Second fill onward, back inside the window: $449.

Extra cost of the restart itself: $250, before any care fee.

Now the same reader on a prepaid annual membership. Three months paused on Ro's $74/mo annual plan is $222 of membership bought and not used, on top of the $250. Total friction: $472 — more than a month of the medication.

The Part D wrinkle, if it applies to you

If you paused and paid cash in the meantime, none of that spending counted. Novo says so on its own pharmacy page: "By opting to pay outside of your insurance, any money spent will not count toward your out-of-pocket limits or deductible."⁸

For 2026, Medicare.gov puts the Part D out-of-pocket threshold for catastrophic coverage at $2,100, with plan deductibles capped at $615.⁹ A cash-paid gap moves you no closer to either, and the threshold resets with the calendar year regardless.

What we could not establish

We could not verify Found's refund terms. The page at joinfound.com/terms returned a 404 on 7 August 2026, so we have reported only what Found's pricing page states — that the $169 rate is based on twelve-month plans paid up front — and have made no claim about what is or is not refundable.

We could not find a published regular price for Lilly's 2.5 mg Zepbound tier outside the 45-day window; the page gives a $499 to $699 range without breaking it out by dose, and the per-dose detail above is Ro's.

And we could not price any restart through insurance, because plan-level cost sharing is not published per drug.

Related: what happens to your price at maintenance, switching from compounded to branded, and our Ro review and Found review, which take both of those bills apart line by line.

Wegovy® and Ozempic® are registered trademarks of Novo Nordisk A/S; Zepbound® and Mounjaro® are registered trademarks of Eli Lilly and Company.